Target intelligence / Profile preview

WD repeat-containing protein 62 (WDR62)

Target
WDR62
Molecular classification
Scaffold protein, WD-repeat family protein, Spindle pole-associated protein, Other (not a receptor, enzyme, ion channel, transporter, or transcription factor)
01

Overview

WD repeat-containing protein 62 (WDR62) is a large scaffold protein belonging to the WD-repeat family and is highly expressed in neural progenitors during embryonic development[1][3][4]. It localizes predominantly at spindle poles during mitosis, ensuring spindle formation, orientation, and dynamics, which is essential for neurogenesis and proper cerebral cortical development[5][6]. WDR62 acts as a scaffold within the JNK signaling pathway, regulating apoptosis, differentiation, and cell survival[3][4]. Mutations in WDR62 cause neurodevelopmental disorders, notably autosomal recessive primary microcephaly (MCPH) and other cortical malformations[1][5][6]. Aberrant expression has also been linked to tumor progression and chemoresistance in several cancer types[4]. In the male reproductive system, WDR62 is necessary for proper spermatogenesis[2]. The protein’s broad involvement in neurodevelopment and oncogenesis makes it a research target, though direct pharmacological modulators are lacking.

Other names
WDR62WD repeat domain 62C19orf14MCPH2DKFZP434J046FLJ33298
02

Mechanism of action

Potential mechanisms involve modulation of neurogenesis, mitotic spindle organization, and JNK pathway activity; however, these are theoretical as direct-targeting drugs are not available

03

Biological functions

Mitotic spindle pole assembly and organizationRegulation of neurogenesis and cerebral cortical developmentCell cycle control (especially mitotic progression)Apoptosis regulationSignal transduction (as part of the JNK signaling cascade)Regulation of centriole duplication and cilium assembly/disassemblyCell proliferation (notably in neural progenitors and glial cells)
04

Disease associations

Neurodevelopmental disease (e.g., autosomal recessive primary microcephaly (MCPH), lissencephaly, pachygyria, polymicrogyria)Cancer (e.g., glioma, lung adenocarcinoma, bladder cancer, colorectal cancer, prostate cancer)Male infertility (defects in spermatogenesis)Other severe brain malformations
05

Safety considerations

Targeting WDR62 could affect neurodevelopment and cell division, risking neurodevelopmental defects and impaired cell proliferationPotential therapeutic challenges include the essential roles in mitosis and possible consequences on fertility and neural health if inhibited
06

Interacting drugs

No approved drugs directly target WDR62 as of current knowledge; WDR62’s role in signaling cascades (e.g., JNK pathway) places it as a potential therapeutic target, but no specific modulators are in clinical use
07

Biomarkers

Mutations in WDR62 (e.g., D955AfsX112) serve as biomarkers for autosomal recessive primary microcephaly and related brain malformationsOverexpression in tumors could be used as a biomarker for aggressive cancer phenotypes

Beyond the preview

Go deeper on WD repeat-containing protein 62 (WDR62).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on WD repeat-containing protein 62 (WDR62).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call